Neurocrine Biosciences
NBIX
#1640
Rank
$9.79 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ USA
Country
$103.54
Share price
-0.44%
Change (1 day)
7.26%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2021 (TTM): $0.09 B

According to Neurocrine Biosciences 's latest financial reports the company's current earnings (TTM) are $0.09 B. In 2020 the company made an earning of $0.13 B an increase over its 2019 earnings that were of $0.07 B. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Neurocrine Biosciences from 2001 to 2021

Year Earnings Change
2021 (TTM)$0.09 B-29.61%
2020$0.13 B77.7%
2019$0.07 B49.9%
2018$0.05 B-142.02%
2017-$0.13 B-15.44%
2016-$0.15 B56.44%
2015-$0.1 B46.25%
2014-$0.07 B29.66%
2013-$0.05 B-3530.8%
2012$1.44 M-95.73%
2011$0.03 B-525.73%
2010-$7.97 M-83.29%
2009-$0.05 B-45.38%
2008-$0.09 B-58.87%
2007-$0.22 B87.3%
2006-$0.12 B351.97%
2005-$0.03 B-52.09%
2004-$0.06 B-10.98%
2003-$0.06 B-43.26%
2002-$0.11 B136.12%
2001-$0.05 B